USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Metabolic Explorer

USPTO PatentsView assignee record - 31 granted patents across 9 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture).

RSS updates for this company

The verdict

According to USPTO PatentsView, Metabolic ranks #10,099 of 49,997 tracked US assignees by granted-patent volume, with 31 patents across 9 technology areas.

#10,099
of 49,997 US assignees by volume
43rd percentile
by Innovation Score (33.0/100)
14.4
avg claims per patent
-37%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10099 · Foreign Corporation #10,099 · 31 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-SMALL 31 grants
  • UPPER-Q #10,099/49,997
  • PHOTO-FINISH Mawetal
  • CPC-NARROW C12P · 9 areas
  • INNOV-THIN 33.0/100
  • CLAIMS-RICH 14.4 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DOWN -37% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Mawetal LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Metabolic’s 33.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Metabolic

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Metabolic's Innovation Score is 33.0/100 (43rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Metabolic?

Each dot is one of Metabolic’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Metabolic’s own 14.4 claims/patent is ABOVE the 13.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Metabolic vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 30.93131.1 5101520 Granted patents (volume) Avg claims / patent MD Healthcare Inc. - 31, 5.77MD HealthcareMedtrum Technologies Inc. - 31, 10.94MedtrumMeishan Boya Advanced Materials Co., Ltd. - 31, 17.55Meishan Boya Adva…Merck Serono SA - 31, 18.94Merck SeronoMicrodose Therapeutx, Inc. - 31, 13.87Microdose Therape…Mawetal LLC - 31, 6.71MawetalMentor Worldwide, LLC - 31, 14.42Mentor WorldwideMicro Mobio Corporation - 31, 18.39Micro MobioMetabolic Explorer - 31, 14.42Metabolic Explorer
Metabolic vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Metabolic's grants concentrate

Metabolic Explorer is a focused PatentsView assignee: 9 CPC subclasses with 100% of grants classified under C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture). Peak complete grant year is 2015 (10 grants) versus a trough of 1 in 2017. By volume, Metabolic sits between MD Healthcare Inc. and Micro Mobio Corporation.

Metabolic's three-year grant acceleration

Metabolic Explorer shows 3 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Metabolic's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Metabolic holds 31 patents at rank #10,097, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Metabolic

By rank, the assignees closest to #10,097 in granted patent volume.

Leaders in C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…)

Other assignees with the most granted patents in Metabolic's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Metabolic, neither rank-band nor same-CPC leaders (those blocks stay above). In C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…), Metabolic ranks #53 of 1,268 assignees by patent count in that subclass.

Metabolic's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 43rd percentile higher than 43% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

024681012 20152016201720192020202120222023 2
USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Metabolic Explorer patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 10 32.3%
2016 6 19.4%
2017 1 3.2%
2019 2 6.5%
2020 5 16.1%
2021 4 12.9%
2022 1 3.2%
2023 2 6.5%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Metabolic Explorer's patent record in context - here's where to go next.

  • Metabolic Explorer's lead technology class is C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture), 100% of its portfolio - see every assignee active in that class. Explore C12P
  • Ranked #10,099 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Metabolic Explorer against MD Healthcare Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 33.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.